CONFERENCE COMMITTEE REPORT NO. 10

                            Honolulu, Hawaii
                                            , 1999

                            RE:   S.B. No. 957
                                  S.D. 2
                                  H.D. 1
                                  C.D. 1




Honorable Norman Mizuguchi
President of the Senate
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Sir:

     Your Committee on Conference on the disagreeing vote of the
Senate to the amendments proposed by the House of Representatives
in S.B. No. 957, S.D. 2, H.D. 1, entitled:  

     "A BILL FOR AN ACT RELATING TO MOTOR VEHICLE INSURANCE," 

having met, and after full and free discussion, has agreed to
recommend and does recommend to the respective Houses the final
passage of this bill in an amended form.

     The purpose of this measure is to extend the deadline for
the Motor Vehicle Insurance Benefits Task Force's (Task Force)
final report to the legislative and executive branches regarding
motor vehicle insurance costs and benefits and the uninsured
motorists problem.  Additionally, the measure extends no-cost
motor vehicle insurance coverage under the joint underwriting
plan to persons who received public assistance medical benefits
prior to July 1, 1994, and who are still receiving these
benefits.

     Upon careful consideration, your Committee on Conference has
amended this measure to:


 
a                                                     SB957 CD1
                            CONFERENCE COMMITTEE REPORT NO. 10
                            Page 2


     (1)  Delete from the purpose section the discussion of
          developing a plan that balances maximum coverage and
          benefits for motor vehicle accident victims with the
          lowest possible cost for motor vehicle insurance
          purchasers;

     (2)  Provide that the measure shall be effective upon its
          approval, rather than on July 1, 2010; and

     (3)  Make technical, nonsubstantive changes. 

     Your Committee on Conference is in accord with the intent
and purpose of S.B. No. 957, S.D. 2, H.D. 1, as amended herein,
and recommends that it pass Final Reading in the form attached
hereto as S.B. No. 957, S.D. 2, H.D. 1, C.D. 1.

                                   Respectfully submitted,

MANAGERS ON THE PART OF THE        MANAGERS ON THE PART OF THE
            HOUSE                             SENATE
                                   
                                   
                                   
______________________________     ______________________________
RON MENOR, Co-Chair                BRIAN T. TANIGUCHI, Co-Chair
                                   
                                   
                                   
______________________________     ______________________________
DENNIS A. ARAKAKI, Co-Chair        BRIAN KANNO, Co-Chair
                                   
                                   
                                   
______________________________     ______________________________
BRIAN Y. YAMANE, Co-Chair          CAROL FUKUNAGA, Co-Chair
                                   
                                   
                                   
______________________________     ______________________________
PAUL WHALEN, Member                ANDREW LEVIN, Co-Chair
                                   
                                   
                                   
                                   ______________________________
                                   ROBERT BUNDA, Member
                                   
                                   
                                   
                                   ______________________________
                                   SAM SLOM, Member

 
a                                                     SB957 CD1
                            CONFERENCE COMMITTEE REPORT NO. 10
                            Page 3




 
a                                                     SB957 CD1